Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.31 |
| ▸ | MRGPRX1 | Q96LB2 | 4/20 | 0.31 |
| ▸ | TSPO | P30536 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | SCN1A | P35498 | 1/20 | 0.30 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.30 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.30 |
| ▸ | ACACB | O00763 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10020107 | 0.89 | MAPT (0.31) | MAPTSMN1; SMN2 | |
| SCHEMBL10020108 | 0.89 | MAPT (0.34) | MAPTSMN1; SMN2FFAR4MRGPRX1TSPO | |
| SCHEMBL9406318 | 0.88 | CYP2C9 (0.36) | MAPTSMN1; SMN2FFAR4MRGPRX1TSPO | |
| SCHEMBL9406321 | 0.88 | CYP2C9 (0.36) | MAPTSMN1; SMN2FFAR4MRGPRX1TSPO | |
| SCHEMBL12741056 | 0.83 | CYP2C9 (0.36) | MAPTSMN1; SMN2PTGDR2MRGPRX1TSPO | |
| SCHEMBL12737594 | 0.83 | CYP2C9 (0.36) | MAPTSMN1; SMN2PTGDR2MRGPRX1TSPO | |
| SCHEMBL10020105 | 0.83 | MAPT (0.32) | MAPTSMN1; SMN2FFAR4MRGPRX1TSPO | |
| SCHEMBL10019934 | 0.81 | RIPK1 (0.37) | PTGDR2 | |
| SCHEMBL10020057 | 0.81 | HPGD (0.40) | MAPTSMN1; SMN2FFAR4PTGDR2CYP2C9 | |
| SCHEMBL10019360 | 0.80 | POLB (0.34) | MAPTSMN1; SMN2FFAR4HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2669263-B1 | COMPOUND CONTAINING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2017-11-22 | — | — | EP | disclosed |
| US-9193908-B2 | Compound having dihydrophenanthrene, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2015-11-24 | — | — | US | disclosed |
| US-9193908-B2 | Compound having dihydrophenanthrene, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2015-11-24 | — | — | US | disclosed |
| US-20130240784-A1 | COMPOUND HAVING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2013-09-19 | — | — | US | disclosed |
| US-20130240784-A1 | COMPOUND HAVING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2013-09-19 | — | — | US | disclosed |
| WO-2012086437-A1 | COMPOUND CONTAINING DIHYDROPHENANTHRENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY | JNC株式会社 (JP) | 2012-06-28 | — | — | WO | disclosed |